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To understand how we achieve quality within a clinical
flow cytometry setting we need to appreciate the difference
between Quality Control (QC) and Quality Assurance
(QA). QC may be defined as a procedure or set of proce-
dures intended to ensure that a manufactured product or
performed service adheres to a defined set of quality cri-
teria. In contrast QA is the planned and systematic activ-
ities implemented in a quality system so that quality
requirements for a product or service will be fulfilled. In
general, one can look at QA as the overall description and
control of a process while QC plays a part in control of the
process. When looking at QA we need to consider how we
control the pre analytical, analytical and post analytical pro-
cess. These processes need to be documented and training
and competence evidenced. The pre analytical process
includes defining the specimen type that is acceptable, how
it will be transported, what identification is required and
whether this is the correct test for the patient. The analyti-
cal process is the part of the process that most scientists
are familiar with. We have to ensure that we conduct the
test using the correct methodology using suitable equip-
ment (validation) and the reagents are suitable for purpose
(verification). As part of the evidence for validation it is
normal to refer to reference methods, published guidelines,
biological reference material, external and internal QC. The
post analytical process, like in the pre analytical process, is
where we again have to look at how the laboratory inter-
faces with it’s users. Consideration has to be given to who
is competent to interpret reports and advise service users,
how we are going to report laboratory results so that the
user understands them and finds them an aid to diagnosis
and treatment. The International Organization for Standar-
dization has developed a set of standards for medical
laboratories, ISO 15189:2012. In the United Kingdom these
standards have been adopted to replace the Clinical
Pathology Accreditation standards and are accredited by
the United Kingdom Accreditation Service (UKAS). The
ISO 15189:2012 standards require laboratories to pay more
attention to traceability of methods through the use of
reference material (WHO, NIBSC etc.), reference methods
and calibration as well as the competence, qualification and
training of laboratory staff, how this is assessed and
reviewed. Through adoption of these processes clinical flow
cytometry laboratories can demonstrate robust analysis to
support clinical diagnosis and are equipped to deal with the
changing environment of clinical flow cytometry.
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